Literature DB >> 28063965

A calix[4]arene derivative and its selective interaction with drugs (clofibric acid, diclofenac and aspirin).

Angela F Danil de Namor1, Maan Al Nuaim2, Jose A Villanueva Salas2, Sophie Bryant2, Brendan Howlin3.   

Abstract

The synthesis and characterisation of a partially substituted calix[4]arene, namely, 5,11,17,23-tetra-tert-butyl,25,27-bis[aminoethoxy] 26,28-dihydroxycalix[4]arene are reported. Its interaction with commonly used pharmaceuticals (clofibric acid, diclofenac and aspirin) was investigated by spectroscopic (1H NMR and UV), electrochemical (conductance measurements) and thermal (titration calorimetry) techniques. It is concluded on the basis of the experimental work and molecular simulation studies that the receptor interacts selectively with these drugs. Preliminary studies on the selective extraction of these pharmaceuticals from water by the calix receptor are reported and the potential for a carrier mediated sensor based on this ligand for 'on site' monitoring of pharmaceuticals is discussed.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aspirin; Calixarenes; Clofibric acid; Diclofenac; Pharmaceuticals; Thermodynamics

Mesh:

Substances:

Year:  2017        PMID: 28063965     DOI: 10.1016/j.ejps.2016.12.027

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  2 in total

1.  Hydration of the Carboxylate Group in Anti-Inflammatory Drugs: ATR-IR and Computational Studies of Aqueous Solution of Sodium Diclofenac.

Authors:  Elena O Levina; Nikita V Penkov; Natalia N Rodionova; Sergey A Tarasov; Daria V Barykina; Mikhail V Vener
Journal:  ACS Omega       Date:  2018-01-10

2.  The supramolecularly complexes of calix[4]arene derivatives toward favipiravir antiviral drug (used to treatment of COVID-19): a DFT study on the geometry optimization, electronic structure and infrared spectroscopy of adsorption and sensing.

Authors:  Numan Yuksel; Ahmet Köse; M Ferdi Fellah
Journal:  J Incl Phenom Macrocycl Chem       Date:  2021-06-05       Impact factor: 1.633

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.